Press Releases | Merrimack Pharmaceuticals
WEBFDA Approval Triggers $225 Million Milestone Payment from Ipsen to Merrimack Merrimack Expects to Hold Special Meeting of Stockholders to Approve Plan of Dissolution in May 2024 Following Approval of Plan of Dissolution, Merrimack Expects to Issue a Liquidating Dividend Currently Estimated to be
Merrimack Pharmaceuticals Announces Notification of Plan to …
WEBCAMBRIDGE, Mass., April 30, 2024 -- ( BUSINESS WIRE )--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") today announced that it has filed notice with NASDAQ...
Merrimack Reports Ipsen Announcement of Approval By The US …
WEBCAMBRIDGE, Mass., February 13, 2024--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") reported that Ipsen, SA ("Ipsen") issued a press release today...
Merrimack Pharmaceuticals, Inc. Announces Stockholder …
WEBMay 10, 2024 · Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent milestone payments related to its ...
Merrimack Pharmaceuticals, Inc. Announces Stockholder …
WEBMay 10, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 10, 2024-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) announced that the stockholders at a Special Meeting held today overwhelmingly approved adopting a Plan of Dissolution. Following that announcement, the Board of Directors declared a …
Press Releases | Merrimack Pharmaceuticals
WEBNov 2, 2023 · CAMBRIDGE, Mass. --(BUSINESS WIRE)--Mar. 9, 2023-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced its full year 2022 financial results for the period ended December 31, 2022 . “We are encouraged by the results of the NAPOLI 3 trial as reported by Ipsen
Merrimack Pharma Wins FDA Approval of Metastatic Pancreatic …
WEBOct 22, 2015 · Merrimack Pharmaceuticals Inc. ( MACK) saw its shares halted for "news pending" due to an approval from the U.S. Food and Drug Administration.
Merrimack Reports Full Year 2022 Financial Results
WEBMar 9, 2023 · Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent milestone payments related to its sale of Onivyde ® to Ipsen S.A. in April 2017. $225 million of these potential milestone payments are tied to the first line metastatic pancreatic ductal...
Shares of Merrimack soar after cancer drug succeeds in trial - STAT
WEBNov 9, 2022 · S hares of Merrimack Pharmaceuticals, a shuttered drug company with no employees or any active research programs, more than doubled Wednesday because of a $225 million windfall that it will...
FDA Approves New First-Line Med for Pancreatic Cancer as Drug’s …
WEBFeb 14, 2024 · The liposome technology used in Onivyde is from Cambridge, Massachusetts-based Merrimack Pharmaceuticals, which initially developed the drug and steered it to a 2015 FDA approval. In 2017,...
Merrimack Pharmaceuticals Inc (MACK) Stock Price & News
WEBMerrimack Pharmaceuticals Inc (MACK) Stock Price & News - Google Finance. Home MACK • NASDAQ. Merrimack Pharmaceuticals Inc. $15.10. After Hours: $15.10. (0.00%) 0.00. Closed: May 13,...
Merrimack Pharmaceuticals stockholders approve plan of …
WEBMay 10, 2024 · Merrimack Pharmaceuticals ( NASDAQ: MACK) said on Friday its stockholders had approved adopting a plan of dissolution. MACK added its board of directors had declared a liquidating cash dividend in ...
Merrimack Pharmaceuticals
WEBMerrimack Pharmaceuticals. Merrimack Pharmaceuticals, Inc. (the “Company”) is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive contingent milestone payments related to its sale of ONIVYDE® to Ipsen S.A. (“Ipsen”) in April 2017. The Company does not have any ongoing research or development ...
MACK Stock Earnings: Merrimack Pharmaceuticals Reported …
WEB5 days ago · May. 16, 2024, 06:53 AM. InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Merrimack Pharmaceuticals (NASDAQ: MACK) just reported results for the first quarter of 2024. Merrimack ...
Merrimack Reports Third Quarter 2022 Financial Results
WEBNov 3, 2022 · Elevation Oncology. - On November 3, 2022 Elevation provided their third quarter investor update and indicated that top line data from its phase 2 CRESTONE Study evaluating the HER3 monoclonal antibody seribantumab in patients with tumors harboring NRG1 fusions are expected in 2024. About Merrimack.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) Increases …
WEB5 days ago · Start Your 30-Day Free Trial. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced a dividend on Thursday, May 16th. Investors of record on Tuesday, May 21st will be paid a dividend of 15.10 per share by the biopharmaceutical company on Friday, May 17th. This represents a yield of 99.87%. The ex-dividend date …
2024-05-10 | NDAQ:MACK | Press Release | Merrimack Pharmaceuticals …
WEBMay 10, 2024 · ABOUT MERRIMACK. Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent milestone payments related to its sale of Onivyde ® to Ipsen S.A. in April 2017. Merrimack received $225 million of these potential milestone …
The Drug Is a ‘Miracle’ but These Families Can’t Get It
WEBFeb 7, 2023 · This Cystic Fibrosis Drug Is a ‘Miracle’ but These Families Can’t Get It - The New York Times. The Drug Is a ‘Miracle’ but These Families Can’t Get It. Vertex Pharmaceuticals is not making its...
Merck's endometrial cancer therapy fails trial | Reuters
WEBMay 9 (Reuters) - Merck (MRK.N) said on Thursday its therapy being tested in certain patients with a type of cancer in the uterus lining failed a late-stage trial. The drugmaker's Keytruda therapy ...
Supernus strikes $400M+ Adamas buyout as its top drug
WEBOct 11, 2021 · (Getty Images) As Supernus' top drug inches toward the patent cliff, the central nervous system-focused drugmaker has struck an M&A deal to quickly expand its portfolio of marketed medicines. In a...
Pharma Focus Europe | Latest Pharmaceutical Industry News and …
WEBReneo Pharmaceuticals and OnKure Announce Proposed Merger. Reneo Pharmaceuticals Inc and OnKure Inc a privatelyheld clinicalstage biopharmaceutical company focused on the development of novel precision medicines in oncology today announced that they have entered.
Merrimack Reports Second Quarter 2022 Financial Results
WEBAug 4, 2022 · Download PDF. CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Aug. 4, 2022-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [ (“Merrimack” or the “Company”)] today announced its second quarter 2022 financial results for the period ended June 30, 2022 .
Turkey reopens ancient church with prized mosaics to Muslim …
WEBMay 10, 2024 · Turkey has opened the ancient Chora church, one of Istanbul's most celebrated Byzantine buildings, to Muslim worshippers after it was used as a museum for more than 70 years, making it the second ...
Merrimack Pharmaceuticals, Inc. Announces Stockholder …
WEBBusiness Wire. Fri, May 10, 2024, 4:30 PM 6 min read. In this article: MACK. CAMBRIDGE, Mass., May 10, 2024 -- ( BUSINESS WIRE )--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or...
Pope Francis to visit Turkey next year, Ecumenical Patriarch says
WEB4 days ago · Pope Francis is planning to visit Turkey next year to mark the anniversary of the First Council of Nicaea, the spiritual head of the world's Orthodox Christians said on Thursday.
Merrimack Pharmaceuticals Announces Notification of Plan to …
WEBApr 30, 2024 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Apr. 30, 2024-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) (“Merrimack” or the “Company”) today announced that it has filed notice with NASDAQ of the Company’s intent to delist its securities from NASDAQ, subject to receipt of stockholder approval of the Plan of Dissolution at the …
Merrimack Pharmaceuticals, Inc. (MACK) Stock Price, News, …
WEBNasdaqGM - Delayed Quote•USD. Merrimack Pharmaceuticals, Inc. (MACK) Follow. 15.13+0.01(+0.07%) At close: 4:00 PM EDT. 15.130.00(0.00%) After hours: 4:00 PM EDT. 1D. 5D. 3M. 6M. YTD. 1Y. 5Y....
One killed, six injured in clashes in western Libyan city, TV channel ...
WEB2 days ago · At least one person was killed and six injured when fierce clashes broke out on Saturday in the city of Zawiya in western Libya, prompting calls for a ceasefire to rescue families trapped in the ...
About Us - Atabay
WEBAtabay was founded in Istanbul by Mr. Ö. Kemalettin Atabay, Pharmacist, in 1939, prior to the outbreak of the Second World War. The company had emerged as a trading business, importing and marketing pharmaceutical products. In the 1940’s, this medium sized commercial operation developed into the production of sulfonamide tablets, which were ...
Merrimack Reports Full Year 2021 Financial Results
WEBMar 9, 2022 · Fourth Quarter and Full Year 2020 Financial Results. Merrimack reported net loss of $2.5 million for the year ended December 31, 2021, or $0.18 per basic share, compared to a net loss of $3.0 million, or $0.23 per basic share, for …
Merrimack Pharmaceuticals, Inc. (MACK) Latest Stock News
WEBCAMBRIDGE, Mass., March 27, 2024--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") today announced that it has received a $225 million …
Investors | Merrimack Pharmaceuticals
WEBApril 30, 2024. Merrimack Pharmaceuticals Announces Notification of Plan to Voluntary Delist Common Stock on NASDAQ Subject to Receipt of Stockholder Approval of Plan of Dissolution. PDF Version. March 27, 2024. Merrimack Receives $225 Million Milestone Payment from Ipsen. PDF Version. View All. Stock Information. Data Provided by Refinitiv.
European Games to be major 2028 Olympic qualifying event
WEB4 days ago · The 2027 European Games in Istanbul will serve as a major qualifying event for the 2028 Los Angeles Olympics, the head of the European Olympic Committees (EOC) said on Thursday.
Putin says Russia is carving out a buffer zone in Ukraine's Kharkiv ...
WEB3 days ago · President Vladimir Putin said on Friday that Russian forces advancing in Ukraine's northeast were carving out a buffer zone to protect Russia from attacks and said the West was "sick in the head ...
- Some results have been removed
Skip to content